| Abnormal expression of the MOS proto-oncogene in human thyroid medullary carcinoma. | thyroid, |
| Viral transfer, transcription, and rescue of a selectable myeloproliferative sarcoma virus in embryonal cell lines: expression of the mos oncogene. | sarcoma, |
| [Molecular cloning and structural organization of the DNA fragments of the rat homologous to the mos oncogene of the mouse sarcoma virus]. | sarcoma, |
| Activation of c-mos oncogene by integration of an endogenous long terminal repeat element during transfection of genomic DNA from mouse skin tumor cells. | skin, |
| Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma. | thyroid, |
| Mutation analysis of the c-mos proto-oncogene in human ovarian teratomas. | ovarian, |
| Identification of COUP-TF as a transcriptional repressor of the c-mos proto-oncogene. | None |
| Assignment of porcine cyclin-dependent kinase 4 (CDK4) and oncogene c-mos (MOS) by nonradioactive nonfluorescence in situ hybridization. | None |
| The mos proto-oncogene product: its role in oocyte maturation, metaphase arrest, and neoplastic transformation. | None |
| Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts. | None |
| Oncogenic activation of murine mos protein kinase by DNA rearrangement of its N-terminal coding region. | None |
| Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling. | None |
| c-mos proto-oncogene product is partly degraded after release from meiotic arrest and persists during interphase in mouse zygotes. | None |
| The role of c-mos proto-oncoprotein in mammalian meiotic maturation. | None |
| Correlation between physiological and transforming activities of the c-mos proto-oncogene product and identification of an essential Mos domain for these activities. | None |
| Production and characterization of a monoclonal antibody to the v-mos oncogene protein. | None |
| [The crucial role of the proto-oncogene c-mos in regulation of oocyte maturation]. | None |
| The cyclin B2 component of MPF is a substrate for the c-mos(xe) proto-oncogene product. | None |
| Effects of the v-mos oncogene on Xenopus development: meiotic induction in oocytes and mitotic arrest in cleaving embryos. | None |
| [The product of c-mos proto-oncogene is expressed in oocytes and functions as a cytostatic factor (CSF)]. | None |